Edition:
India

People: Intra-Cellular Therapies Inc (ITCI.OQ)

ITCI.OQ on NASDAQ Stock Exchange Global Select Market

13.97USD
15 Feb 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$13.97
Open
$13.74
Day's High
$13.98
Day's Low
$13.57
Volume
101,360
Avg. Vol
132,873
52-wk High
$25.74
52-wk Low
$10.24

Halstead, Michael 

Mr. Michael I. Halstead is the Senior Vice President, General Counsel, Secretary of Intra-Cellular Therapies, Inc. From July 2005 until December 2013, Mr. Halstead served in a number of leadership positions at Warner Chilcott plc. Most recently he was Senior Vice President, Corporate Development at Warner Chilcott where he directed the company’s corporate development, legal and human resources functions. Prior to that, Mr. Halstead was an attorney at the firm of Davis Polk & Wardwell. Mr. Halstead received his bachelor’s degree from Boston University and his Juris Doctor degree from Villanova University School of Law.

Basic Compensation

Total Annual Compensation, USD 683,000
Restricted Stock Award, USD 966,961
Long-Term Incentive Plans, USD --
All Other, USD 766,316
Fiscal Year Total, USD 2,416,280

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Lawrence Hineline

2,351,950

Mark Neumann

--

Andrew Satlin

2,018,330

Robert Davis

2,008,300

Michael Halstead

2,416,280

Suresh Durgam

--
As Of  31 Dec 2017